Focus Partners Wealth Boosts Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Focus Partners Wealth increased its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 30.0% during the 4th quarter, HoldingsChannel reports. The firm owned 2,275 shares of the biotechnology company’s stock after buying an additional 525 shares during the period. Focus Partners Wealth’s holdings in Sarepta Therapeutics were worth $277,000 at the end of […]
